#bionano

[raphavisses]

Stripy Nanoparticles Revisited

Challenging published results is an onerous but necessary task. Today, our article entitled Stripy Nanoparticles Revisited has been published in Small, three years after its initial submission to this journal (3/12/09) and about three  and a half years after the first submission (to Nature Materials, 21/07/09). As its title indicates, the article challenges the evidence for the existence and…

[e-glyde]

Taking heavy inspiration from Halo Infinite in her suit design.

Compressor pack features include:

Plug and Play Tanks!

Monitoring of intake and outtake!

RGB!!!

Not included:

Bionano bot storage. (Anderson Bell® is not responsible for any injuries incurred from non-recommended uses of Anderson Bell® diving equipment)

[trendstodaynet]

Bionano Shares Rise 19% in Direct ATM Offering (BNGO:NASDAQ)

Massimo Giachetti Bionano Genomics (NASDAQ: BNGO) shares rose 19% Friday afternoon after the company announced a $10 million registered direct offering priced to market under Nasdaq rules. bionano (NASDAQ: BNGO) said it has entered into an agreement with certain institutional investors to purchase and

[third-new]

Bionano Shares Gain 19% on Direct ATM Offering (BNGO:NASDAQ)

Massimo Giachetti Bionano Genomics (NASDAQ:BNGO) shares rallied 19% Friday afternoon after the company announced a $10 million registered direct offering at market price under Nasdaq rules. bionano (NASDAQ:BNGO) said it had entered into an agreement with certain institutional investors to purchase i Source link

[newtras]

Bionano Shares Gain 19% on Direct ATM Offering (BNGO:NASDAQ)

Massimo Giachetti Bionano Genomics (NASDAQ:BNGO) shares rallied 19% Friday afternoon after the company announced a $10 million registered direct offering at market price under Nasdaq rules. bionano (NASDAQ:BNGO) said it had entered into an agreement with certain institutional investors to purchase i Source link

[satrthere]

Bionano Shares Gain 19% on Direct ATM Offering (BNGO:NASDAQ)

Massimo Giachetti Bionano Genomics (NASDAQ:BNGO) shares rallied 19% Friday afternoon after the company announced a $10 million registered direct offering at market price under Nasdaq rules. bionano (NASDAQ:BNGO) said it had entered into an agreement with certain institutional investors to purchase i Source link

[leedsomics]

Guava cv. Allahabad Safeda Chromosome scale assembly and comparative genomics decodes breeder choice marker trait association for pink pulp colour

Deciphering chromosomal length genome assemblies has the potential to unravel an organisms evolutionary relationships and genetic mapping of traits of commercial importance. We assembled guava genome using a hybrid sequencing approach with ~450x depth Illumina short reads, ~35x PacBio long reads and Bionano maps to ~594 MB Scaffold length on 11 pseudo chromosomes (~479 MB contig length). Maker pipeline predicted 17,395 genes, 23% greater from earlier draft produced in same cultivar Allahabad Safeda. The genome assembly clarified guava evolutionary history, for example revealing predominance of gene expansion by dispersed duplications, in particular contributing to abundance of monoterpene synthases; and supporting evidence of a whole genome duplication event in guava as in other Myrtaceae. Guava breeders have been aiming to reduce screening time for selecting pink pulp colour progenies using marker-trait associations, but a previous comparative transcriptomics and comparative genomics approach with draft genome assembly to identify the effector gene associated with pink pulp was unsuccessful. Here, genome re-sequencing with Illumina short reads at ~25x depth of 20 pink fleshed and/or non-coloured guava cultivars and comprehensive analysis for genes in the carotenoid biosynthesis pathway identified structural variations in Phytoene Synthase 2. Further, ddRAD based association mapping in core-collection of 82 coloured and non-coloured genotypes from Indian sub-continent found strong association with the same causal gene. Subsequently, we developed PCR based Indel/SSR breeder friendly marker that can readily be scored in routine agarose gels and empowers accurate selection for seedlings that will produce fruits with pink pulp. http://dlvr.it/T4pLzV

[fmarkets]

Bionano Genomics Inc Experiences Remarkable Surge in Revenue, Paving the Way for a Promising Fiscal Period 2. https://csimarket.com/stocks/news.php?code=BNGO&date=2023-11-09223109&utm_source=dlvr.it&utm_medium=tumblr

[biotech-news-feed]

Through its OEM partner A-smart MedTech, Bionano can now sell two more sample prep products for IVD applications in reproductive health in China. #BioTech #science

[raphavisses]

Our First Pre-Registration is Live! Replication of...

After months of efforts, my co-authors and I are absolutely delighted to share this preprint, which is special in many ways: Said, Maha, Mustafa Gharib, Samia Zrig, and Raphaël Lévy. 2023. “Replication of “Carbon-dot-based Dual-emission Nanohybrid Produces a Ratiometric Fluorescent Sensor for in Vivo Imaging of Cellular Copper Ions”” OSF Preprints. November 29. doi:10.31219/osf.io/kf9qe. This…

[fanona1]

This Machine Fights Technofascists writes:

"What To Tell The Liberal Normies -

None of us, not one, who avoided the jibby jab regret NOT taking it.

When are those of you who got duped and deceived and double crossed going to start getting angry about it?

Is it possible that you STILL don't quite understand what was done to you, to your family, to your community, to our institutions, to our entire society?

Is it possible that you are STILL following and trusting and listening to the liberal establishment authorities who bionano raped you?

Is it possible that you STILL believe this was only ever about bats and wet markets and global tensions and "public health"?

Is it possible that you STILL don't know that Silicon Valley social media platforms were developed and funded by military intelligence agencies and handed off to "private owners" as Trojan Horse civilian systems to establish digital totalitarianism?

Is it possible that you STILL believe that the predator class loves you and wants the best for you and they would never cause you harm or lie to you in order to save their own skins so they can open their new markets for CRISPR engineering and cybernetic steering?

You.Are.Wrong.

On all counts.

Get angry.

NOW."

◾️◾️◾️◾️◾️

"So it was that within a few weeks, Andersen and his co-authors had written exactly the paper that Tony Fauci needed them to write, a paper that, without quite saying so, consigned the lab leak theory to the fringes of conspiracy.

If only the world’s largest social media site could push it even further down the rathole!

Fortunately, Fauci had a friend there too.

Fauci may not have known what he’d funded in Wuhan.

But once he found out, he knew better than anyone how to make sure he wouldn’t get blamed for it."

- Alex Berenson, "Unreported Truths" Substack, 7/20/2023

https://alexberenson.substack.com/.../what-did-dr-anthony... See less

[faultfalha]

Bionano genomics is a noble cause, but a bad investment. It is a field of study that has so much potential, but the payoff is not there. The research is difficult, and the results are not always conclusive. The time and money invested in this field could be better spent elsewhere.

[technolgy0411]

Long Read Sequencing Market Size Dynamics Reviewed for Stakeholders in New 2028 Report

An exhaustive evaluation of restrains included in Long Read Sequencing Market report portrays dissimilarity to drivers and hence, gives room for tactical planning. Characteristics that overshadow market progress are as essential as they can be understood to advance different bends for getting hold of lucrative scenarios that are existing in this ever-growing market. Furthermore, insights into the key specialist’s opinions have been well-thought-out to understand this market better.

The study elaborates growth rate of the Long Read Sequencing Market supported and analysed after exhaustive and reliable company profile analysis. The study offers an in-depth investigation, market size, share, insights, evaluation for developing segment and numerous other important market characteristic in the Long Read Sequencing Market industry.

The Prominent/Emerging Players in the Long Read Sequencing Market includes:

Oxford Nanopore Technologies Tataa Biocenter Illumina, Inc Perkinelmer Inc. F. Hoffmann-La Roche Ltd. Baseclear B.V. Bionano Genomics Longas Technologies Pacific Biosciences of California, Inc. Quantapore, Inc. The global Long Read Sequencing Market segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Long Read Sequencing Market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2021–2028.

Long Read Sequencing Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) The report currently provides detailed insights on trends, market share, market size, market value, and trading volume. The global Long Read Sequencing Market report provides a comprehensive analysis of COVID-19 infections and how it has impacted market growth. This study explains the future opportunities for market participants. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory.

Research objectives:

To study and analyze the global Long Read Sequencing Market size by key regions/countries, product type and application, history data from 2018 to 2020, and forecast to 2028. To understand the structure of Long Read Sequencing Market by identifying its various sub segments. Focuses on the key global Long Read Sequencing Market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Long Read Sequencing Market with respect to individual growth trends, future prospects, and their contribution to the total market. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). To project the size of Long Read Sequencing Market submarkets, with respect to key regions (along with their respective key countries). To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. Table of Contents: Long Read Sequencing Market

Part 1: Overview of Long Read Sequencing Market Part 2: Long Read Sequencing Market Carts: Global Market Status and Forecast by Regions Part 3: Global Market Status and Forecast by Types Part 4: Global Market Status and Forecast by Downstream Industry Part 5: Market Driving Factor Analysis Part 6: Market Competition Status by Major Manufacturers Part 7: Major Manufacturers Introduction and Market Data Part 8: Upstream and Downstream Market Analysis Part 9: Cost and Gross Margin Analysis Part 10: Marketing Status Analysis Part 11: Market Report Conclusion Part 12: Long Read Sequencing Market: Research Methodology and Reference About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

[cavixorg]

BIONANO Genomics is a gene-mapping company that’s only a matter of time before it can rise in the future. Its shares have skyrocketed in the past, and the BIONANO genomics forecast is seen as a stock that will likely make progress. Is BNGO A Good Stock To Buy? It is unclear whether BIONANO, a stock that has grown rapidly in the past, will continue to grow at this rate in the future. When it comes to the future of BIONANO genomics, the remarks of specialist analysts and stockbrokers appear to be promising for the time being target price for BNGO stock The median 12 month price goal for BIONANO Genomics Inc is 7.50, with a high estimate of 12.00 and a low estimate of 6.00 from the four analysts who provide 12 month price forecasts. The median forecast reflects a +383.89% gain over the previous price of 1.57. was determined to be Of course, this is not the only stock BIONANO genomics stock forecast. When purchasing stocks, keep in mind that the expectation of not high short term returns. When we look back at the BIONANO genomics stock forecast, it can be used to predict future rises. Because past stock forecast prices provide an excellent opportunity to compare current figures. When we look at the end of December, we can see that BIONANO genomics stock forecast 2022 may have decreased by 1.69. It provides important clues about whether to invest in stock future predictions, as well as current and past tense predictions, as well as predictions made in the coming years. The BNGO stock forecast 2023 is a short term prediction. To determine whether you can meet your objectives, look ahead to a future date, such as BNGO stock forecast 2025. Based on the graphic comments of expert analysts, we can estimate the average value of January and December this year to be 1.67. When it comes to BNGO stock forecast 2030, we can easily say that when we look at the average of the beginning and end of the year, this figure will climb to a large figure of 2.05. In statistics, the likelihood of incorrect data is extremely low. That is why we advise you to pay close attention to BNGO stock price predictions. Is BNGO Buy Or Sell? The average rating score for the company is 3.00. As a result, looking at this statistical data will make it easier for you to decide whether a stock should be sold or purchased. By looking at BNGO stock price prediction, you can decide whether to sell or buy this stock. Should I Buy BNGO Stock? The financial health and growth prospects of BNGO show that it has the potential to underperform the market. It raises the question, “Should I Buy BNGO Stock?” Due to the recent decline, it is not advised to be purchased. If you plan to buy BNGO long term, it should be considered an investment. Who Is BNGO Stock? It manages to drive its investors from curiosity to curiosity with BIONANO forecast. So, who are the shareholders in these companies? Let’s see. BIONANO costs $3.1 million in total. SSgA Funds Management, Inc., BlackRock Fund Advisors, and The Vanguard Group, Inc. are among these shareholders, as are large corporations such as. Is BNGO A Good Company? According to expert analysts, the BIONANO forecast is quite safe. So, is the BIONANO company in which we invested a good one? Yes, analysts are optimistic about the company. How Much Will BNGO Go Up? BIONANO genomics future provides insight into the stock. Looking at the graphic data, we can predict that the BNGO stock will increase by 383.89 percent. Based on this data, the idea of ​​BNGO buy or sell is entirely up to you. BNGO long term is a stock to consider. Is BNGO A US Stock? BIONANO, which will leave you a good profit considering BNGO long term, is a Nasdaq: US stock. Is BNGO In Russell? As part of the 2021 Russell indexes reconstitution, Nasdaq: BNGO announced  that it has been included as a member of the US small cap Russell 2000 Index, effective after the US market opens on Monday, June 28, 2021. In the coming years, BNGO stock predictions are expected to rise.

Those who own may wonder whether to BNGO buy or sell. However, when the price of a stock is low, it can provide significant gains to the investor if we believe it will rise in the coming years based on forecasts. One of the issues to consider is the BNGO stock price target. For price analysis, you should always read and listen to the comments of good, honest, and realistic analysts. This article will be an excellent resource for BNGO stock predictions. Investing in the company gives investors hope for the BIONANO genomics future. The greater the investment in a stock, the more trustworthy the company is to the investor. If the trend continues, the BNGO stock price target will undoubtedly be met. Although whether BNGO is a good stock to buy has caused some hesitancy due to the stock’s recent decline, we believe it will answer the question in the future. That is why you should never ignore BNGO stock price target news. The stock market is complex and volatile. The only way to find out if BNGO is a good stock to buy is to closely monitor the market.

[stocklivemarket]

BIONANO Genomics is a gene-mapping company that’s only a matter of time before it can rise in the future. Its shares have skyrocketed in the past, and the BIONANO genomics forecast is seen as a stock that will likely make progress. Is BNGO A Good Stock To Buy? It is unclear whether BIONANO, a stock that has grown rapidly in the past, will continue to grow at this rate in the future. When it comes to the future of BIONANO genomics, the remarks of specialist analysts and stockbrokers appear to be promising for the time being target price for BNGO stock The median 12 month price goal for BIONANO Genomics Inc is 7.50, with a high estimate of 12.00 and a low estimate of 6.00 from the four analysts who provide 12 month price forecasts. The median forecast reflects a +383.89% gain over the previous price of 1.57. was determined to be Of course, this is not the only stock BIONANO genomics stock forecast. When purchasing stocks, keep in mind that the expectation of not high short term returns. When we look back at the BIONANO genomics stock forecast, it can be used to predict future rises. Because past stock forecast prices provide an excellent opportunity to compare current figures. When we look at the end of December, we can see that BIONANO genomics stock forecast 2022 may have decreased by 1.69. It provides important clues about whether to invest in stock future predictions, as well as current and past tense predictions, as well as predictions made in the coming years. The BNGO stock forecast 2023 is a short term prediction. To determine whether you can meet your objectives, look ahead to a future date, such as BNGO stock forecast 2025. Based on the graphic comments of expert analysts, we can estimate the average value of January and December this year to be 1.67. When it comes to BNGO stock forecast 2030, we can easily say that when we look at the average of the beginning and end of the year, this figure will climb to a large figure of 2.05. In statistics, the likelihood of incorrect data is extremely low. That is why we advise you to pay close attention to BNGO stock price predictions. Is BNGO Buy Or Sell? The average rating score for the company is 3.00. As a result, looking at this statistical data will make it easier for you to decide whether a stock should be sold or purchased. By looking at BNGO stock price prediction, you can decide whether to sell or buy this stock. Should I Buy BNGO Stock? The financial health and growth prospects of BNGO show that it has the potential to underperform the market. It raises the question, “Should I Buy BNGO Stock?” Due to the recent decline, it is not advised to be purchased. If you plan to buy BNGO long term, it should be considered an investment. Who Is BNGO Stock? It manages to drive its investors from curiosity to curiosity with BIONANO forecast. So, who are the shareholders in these companies? Let’s see. BIONANO costs $3.1 million in total. SSgA Funds Management, Inc., BlackRock Fund Advisors, and The Vanguard Group, Inc. are among these shareholders, as are large corporations such as. Is BNGO A Good Company? According to expert analysts, the BIONANO forecast is quite safe. So, is the BIONANO company in which we invested a good one? Yes, analysts are optimistic about the company. How Much Will BNGO Go Up? BIONANO genomics future provides insight into the stock. Looking at the graphic data, we can predict that the BNGO stock will increase by 383.89 percent. Based on this data, the idea of ​​BNGO buy or sell is entirely up to you. BNGO long term is a stock to consider. Is BNGO A US Stock? BIONANO, which will leave you a good profit considering BNGO long term, is a Nasdaq: US stock. Is BNGO In Russell? As part of the 2021 Russell indexes reconstitution, Nasdaq: BNGO announced  that it has been included as a member of the US small cap Russell 2000 Index, effective after the US market opens on Monday, June 28, 2021. In the coming years, BNGO stock predictions are expected to rise.

Those who own may wonder whether to BNGO buy or sell. However, when the price of a stock is low, it can provide significant gains to the investor if we believe it will rise in the coming years based on forecasts. One of the issues to consider is the BNGO stock price target. For price analysis, you should always read and listen to the comments of good, honest, and realistic analysts. This article will be an excellent resource for BNGO stock predictions. Investing in the company gives investors hope for the BIONANO genomics future. The greater the investment in a stock, the more trustworthy the company is to the investor. If the trend continues, the BNGO stock price target will undoubtedly be met. Although whether BNGO is a good stock to buy has caused some hesitancy due to the stock’s recent decline, we believe it will answer the question in the future. That is why you should never ignore BNGO stock price target news. The stock market is complex and volatile. The only way to find out if BNGO is a good stock to buy is to closely monitor the market.